- Global Pharma News & Resources

Press Releases - 2022-04-05

Date Title Company
05-Apr-2022 Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 28, 2022 Businesswire
05-Apr-2022 Alnylam Announces Retirement of Steven Paul, M.D. from Board of Directors Businesswire
05-Apr-2022 Biophytis appoints Philippe Rousseau as Chief Financial Officer Biophytis
05-Apr-2022 Global Disinfectant and Decontamination Market Report 2022-2026: Analysis by Medical Devices Disinfectants, Enzymatic Cleaners, and Surface Disinfectants - Businesswire
05-Apr-2022 Global RNAi Therapeutics Market Analysis Report 2022: Growing Focus on Personalized Medicines & New AI Technologies in RNAi Therapeutics Market - Businesswire
05-Apr-2022 Advicenne: A Case Report Highlights the Interest of a Long-Term Treatment with ADV-7103 in dRTA Businesswire
05-Apr-2022 Tevogen Bio Expands Executive Leadership Team to Accelerate Operational Growth and Commercial Readiness Businesswire
05-Apr-2022 North America Monoclonal Antibodies Market to 2030 - by Source, Category, Production Type, Application, End-user and Country - Businesswire
05-Apr-2022 Cardea Bio Completes Planned Launch of CRISPR QC Businesswire
05-Apr-2022 Accenture Invests in Good Chemistry Company to Help Drive Quantum Computing Advancements in Materials and Life Sciences Businesswire
05-Apr-2022 Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Certain Forms of Relapsed or Refractory Large B-cell Lymphoma Businesswire
05-Apr-2022 Real Chemistry Acquires conversationHEALTH Businesswire
05-Apr-2022 Two Day Virtual Drug Development Process Training Course: Key to Success from Concept to Commercialization (May 12-13, 2022) - Businesswire
05-Apr-2022 Two Day Virtual FDA Regulation of OTC Drug Products Course: What It Is, How to Analyze It, Make It Work for You - May 4th-5th, 2022 - Businesswire
05-Apr-2022 Two Day Virtual GMPs for the Life Sciences Course (June 9-10, 2022) - Businesswire
05-Apr-2022 AVM Biotechnology Awarded $1.6 Million Phase II SBIR Grant to Study AVM0703’s Potential to Reverse Type 1 Diabetes Businesswire
05-Apr-2022 Two Day Virtual Pharmaceutical Analytical Method Validation, Verification and Transfer Course (April 11-12, 2022) - Businesswire
05-Apr-2022 AccuStem Announces Private Placement of Common Stock AccuStem
05-Apr-2022 Team of scientists and clinicians wins global award for transforming breast cancer treatment ICR
05-Apr-2022 Achilles Therapeutics to Host KOL Webcast to Highlight TRACERx Study Presentations from the 2022 AACR Annual Meeting Achilles Therapeutics